Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection

被引:1
作者
Wu, Yanhua [1 ,2 ]
Pan, Yuchen [1 ,2 ]
Su, Kaisheng [2 ]
Zhang, Yangyu [1 ,2 ]
Jia, Zhifang [1 ,2 ]
Yi, Jiaxin [2 ]
Lv, Haiyong [2 ]
Zhang, Lihuan [3 ]
Xue, Mingyang [4 ]
Cao, Donghui [2 ]
Jiang, Jing [1 ,2 ]
机构
[1] First Hosp Jilin Univ, Ctr Infect Dis & Pathogen Biol, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Clin Epidemiol, Changchun, Peoples R China
[3] Second Hosp Jilin Univ, Changchun, Peoples R China
[4] Jilin Univ, Sch Publ Hlth, Changchun, Peoples R China
关键词
SARS-CoV-2; Omicron; Delta; clinical outcome; meta-analysis; MORTALITY; SEVERITY; COVID-19; PERIODS; STATES;
D O I
10.3389/fmicb.2023.1051104
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundThe COVID-19 pandemic brings great pressure to the public health systems. This meta-analysis aimed to compare the clinical outcomes among different virus variants, to clarify their impact on medical resources and to provide evidence for the formulation of epidemic prevention policies. MethodsA systematic literature search was performed in the PubMed, Embase, and Cochrane Library databases using the key words "Omicron" and "Delta." The adjusted Risk ratios (RRs), Odds ratios (ORs) and Hazard ratios (HRs) were extracted, and RRs and Rate difference % (RD%) were used to interpret the risk estimates of the outcomes ultimately. ResultsForty-three studies were included, with 3,812,681 and 14,926,841 individuals infected with SARS-CoV-2 Delta and Omicron variant, respectively. The relative risks of hospitalization, death, ICU admission, and mechanical ventilation use after infection with the Omicron variant were all significantly reduced compared those after infection with the Delta variant (RRhospitalization = 0.45, 95%CI: 0.40-0.52; RRdeath = 0.37, 95%CI: 0.30-0.45; RRICU = 0.35, 95%CI: 0.29-0.42; RRmechanical ventilation = 0.33, 95%CI: 0.25-0.44). The change of both absolute and relative risks for hospitalization was more evident (RR = 0.47, 95%CI: 0.42-0.53(sic)RD% =10.61, 95%CI: 8.64-12.59) and a significant increase was observed for the absolute differences in death in the elderly (RD% = 5.60, 95CI%: 4.65-6.55); the change of the absolute differences in the risk of hospitalization and death were most markedly observed in the patients with booster vaccination (RD%(hospitalization) = 8.60, 95CI%: 5.95-11.24; RD%(death) = 3.70, 95CI%: 0.34-7.06). ConclusionThe ability of the Omicron variant to cause severe clinical events has decreased significantly, as compared with the Delta variant, but vulnerable populations still need to be vigilant. There was no interaction between the vaccination doses and different variants.
引用
收藏
页数:14
相关论文
共 69 条
[1]  
Adjei S, 2022, MMWR-MORBID MORTAL W, V71, P1182, DOI 10.15585/mmwr.mm7137a4
[2]   Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) [J].
Ahn, Dae-Gyun ;
Shin, Hye-Jin ;
Kim, Mi-Hwa ;
Lee, Sunhee ;
Kim, Hae-Soo ;
Myoung, Jinjong ;
Kim, Bum-Tae ;
Kim, Seong-Jun .
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 30 (03) :313-324
[3]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]
[4]  
Ann-Davies M, 2022, medRxiv, DOI [10.1101/2022.01.12.22269148, 10.1101/2022.01.12.22269148, DOI 10.1101/2022.01.12.22269148]
[5]   Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines [J].
Araf, Yusha ;
Akter, Fariya ;
Tang, Yan-dong ;
Fatemi, Rabeya ;
Parvez, Md Sorwer Alam ;
Zheng, Chunfu ;
Hossain, Md Golzar .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :1825-1832
[6]   BNT162b2 Vaccine Booster and Mortality Due to Covid-19 [J].
Arbel, Ronen ;
Hammerman, Ariel ;
Sergienko, Ruslan ;
Friger, Michael ;
Peretz, Alon ;
Netzer, Doron ;
Yaron, Shlomit .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) :2413-2420
[7]   Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study [J].
Auvigne, Vincent ;
Vaux, Sophie ;
Le Strat, Yann ;
Schaeffer, Justine ;
Fournier, Lucie ;
Tamandjou, Cynthia ;
Montagnat, Charline ;
Coignard, Bruno ;
Levy-Bruhl, Daniel ;
du Chatelet, Isabelle Parent .
ECLINICALMEDICINE, 2022, 48
[8]   Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study [J].
Bager, Peter ;
Wohlfahrt, Jan ;
Bhatt, Samir ;
Stegger, Marc ;
Legarth, Rebecca ;
Moller, Camilla Holten ;
Skov, Robert Leo ;
Valentiner-Branth, Palle ;
Voldstedlund, Marianne ;
Fischer, Thea K. ;
Simonsen, Lone ;
Kirkby, Nikolai Soren ;
Thomsen, Marianne Kragh ;
Spiess, Katja ;
Marving, Ellinor ;
Larsen, Nicolai Balle ;
Lillebaek, Troels ;
Ullum, Henrik ;
Molbak, Kare ;
Krause, Tyra Grove .
LANCET INFECTIOUS DISEASES, 2022, 22 (07) :967-976
[9]   The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections [J].
Baker, Meghan A. ;
Sands, Kenneth E. ;
Huang, Susan S. ;
Kleinman, Ken ;
Septimus, Edward J. ;
Varma, Neha ;
Blanchard, Jackie ;
Poland, Russell E. ;
Coady, Micaela H. ;
Yokoe, Deborah S. ;
Fraker, Sarah ;
Froman, Allison ;
Moody, Julia ;
Goldin, Laurel ;
Isaacs, Amanda ;
Kleja, Kacie ;
Korwek, Kimberly M. ;
Stelling, John ;
Clark, Adam ;
Platt, Richard ;
Perlin, Jonathan B. .
CLINICAL INFECTIOUS DISEASES, 2022, 74 (10) :1748-1754
[10]   Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant [J].
Bansal, Kanika ;
Kumar, Sanjeet .
VIRUS RESEARCH, 2022, 315